Low risk prostate cancer in men under age 65: The case for definitive treatment

Thomas L. Jang, Ofer Yossepowitch, Fernando J. Bianco, Peter T. Scardino*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Low risk prostate cancer in men under age 65: The case for definitive treatment'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science